Last reviewed · How we verify
100000 Cases Real World Research of the Safety and Efficacy Revaluation of Cefuroxime Axetil Dispersible Tablets After Listing
1. National, large-scale, standardized, standardized, real-world research; 2. Prospective, single - arm open, non - interventional, registration, multi - center clinical study; 3. in the use of cefuroxime axetil dispersible tablets in the hospital, according to the principle of voluntary selection of 200; 4. registration of the use of cefuroxime axetil dispersion tablets patients; 5. Target sample size of 100,000 cases; 6. Exemption from informed consent for ethical review applications; 7. Antibiotic drug safety re-evaluation of large data.
Details
| Lead sponsor | Jiangsu Famous Medical Technology Co., Ltd. |
|---|---|
| Status | UNKNOWN |
| Enrolment | 100000 |
| Start date | 2017-01 |
| Completion | 2019-11 |
Conditions
- Infectious Disease
Interventions
- Cefuroxime Axetil Dispersible Tablets
Primary outcomes
- Bacterial clearance — 1 to 14 days after the use of Cefuroxime Axetil Dispersible Tablets，
1.clear 2.Assume purge 3.Not cleared 4.Assume not cleared 5.Partially cleared 6.replace 7.Re-infection 8.Colonization 9.Can not be evaluated